Medicines beyond barriers

About us

Gate2Brain is an early-stage biotech company launched to improve drug delivery across biological barriers through the use of a radically innovative peptide-based patented technology.

Our lead asset (G2B-001) is a first-in-class therapeutic approach for solid tumors presenting harsh barriers to anticancer drug delivery. 

We focus on pediatric diseases such as Diffuse Intrinsic Pontine Glioma (DIPG).

Contact

Parc Científic de Barcelona
Street: Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain